A morphological subset of circulating tumor cells in advanced prostate cancer reveals a potential biomarker for clinical outcomes.

被引：0
|
作者：
Wang, Jasmine Jiemei
Cavassani, Karen Angelica
Teng, Pai-Chi
Chen, Jie-Fu
Jan, Yu Jen
Chu, Gina Chia-Yi
Lee, Yi-Te
Gao, Allen
Di Vizio, Dolores
Chung, Leland W. K.
You, Sungyong
Zhu, Yazhen
Freeman, Michael
Rogatko, Andre
Yang, Ju Dong
Tseng, Hsian-Rong
Posadas, Edwin Melencio
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA USA
[2] Samuel Oschin Comprehens Canc Inst, Cedars Sinai Med Ctr, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] Univ Calif Davis Comprehens Canc Ctr, Sacramento, CA USA
[5] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA
[6] Cedars Sinai Med Ctr, West Hollywood, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e17008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17008
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Nuclear size of circulating tumor cells in advanced prostate cancer to reveal a potential biomarker for clinical outcomes and androgen receptor indifference.
    Wang, Jasmine Jiemei
    Cavassani, Karen Angelica
    Teng Pai-Chi
    Chen Jie-Fu
    Jan, Yu Jen
    Chu, Gina Chia-Yi
    Lee, Yi-Te
    Gao, Allen
    Di Vizio, Dolores
    Chung, Leland W. K.
    You Sungyong
    Zhu Yazhen
    Freeman, Michael
    Rogatko, Andre
    Yang, Ju Dong
    Tseng, Hsian-Rong
    Posadas, Edwin Melencio
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [2] Morphological Subsets of Circulating Tumor Cells in Advanced Prostate Cancers: A Potential Biomarker for Patients with Visceral Metastases
    Chen, Jie-Fu
    Huang, Jiaoti
    Chung, Leland
    Tseng, Hsian-Rong
    Posadas, Edwin
    FASEB JOURNAL, 2015, 29
  • [3] Circulating tumor cells with small nuclear size: A novel biomarker for survival and clinical outcomes in advanced prostate cancer.
    Wang, Jasmine Jiemei
    Teng, Pai-Chi
    Jan, Yu Jen
    Chen, Jie-Fu
    Cook-Wiens, Galen
    Yao, Nu
    Chu, Gina Chia-Yi
    Chen, Pin-Jung
    Ho, Hao
    Lee, Yi-Te
    Huang, Jiaoti
    Li, Ker-Chau
    Chung, Leland W. K.
    Zhu, Yazhen
    Freeman, Michael
    Rogatko, Andre
    Yang, Ju Dong
    Tseng, Hsian-Rong
    Posadas, Edwin Melencio
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Clinical Utility of Circulating Tumor Cells in Advanced Prostate Cancer
    Zhang, Tian
    Armstrong, Andrew J.
    CURRENT ONCOLOGY REPORTS, 2016, 18 (01) : 1 - 8
  • [5] Clinical Utility of Circulating Tumor Cells in Advanced Prostate Cancer
    Tian Zhang
    Andrew J. Armstrong
    Current Oncology Reports, 2016, 18
  • [6] Circulating tumor cells and advanced prostate cancer
    Murez, Thibaut
    Droupy, Stephane
    Rebillard, Xavier
    Alix-Panabieres, Catherine
    BULLETIN DU CANCER, 2012, 99 : S4 - S15
  • [7] Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential
    Fredsoe, Jacob
    Rasmussen, Anne K. I.
    Mouritzen, Peter
    Bjerre, Marianne T.
    Ostergren, Peter
    Fode, Mikkel
    Borre, Michael
    Sorensen, Karina D.
    DIAGNOSTICS, 2020, 10 (04)
  • [8] The Clinical Application and Potential Roles of Circulating Tumor Cells in Bladder Cancer and Prostate Cancer
    Yan, Hang
    Dittmar, Florian
    Schagdarsurengin, Undraga
    Wagenlehner, Florian
    UROLOGY, 2020, 145 : 30 - 37
  • [9] Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential
    Galletti, Giuseppe
    Portella, Luigi
    Tagawa, Scott T.
    Kirby, Brian J.
    Giannakakou, Paraskevi
    Nanus, David M.
    MOLECULAR DIAGNOSIS & THERAPY, 2014, 18 (04) : 389 - 402
  • [10] Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential
    Giuseppe Galletti
    Luigi Portella
    Scott T. Tagawa
    Brian J. Kirby
    Paraskevi Giannakakou
    David M. Nanus
    Molecular Diagnosis & Therapy, 2014, 18 : 389 - 402
12345